The role of epidural anaesthesia and analgesia in the perioperative period has long been highly contentious, with contrasting messages from the available literature. Proponents cite benefits such as improved analgesia 1, 2 , a reduction in ileus after colonic surgery 3, 4 and perhaps, improved outcome 5, 6 . Sceptics tend to focus on the rare but potentially devastating complications 7, 8 , the hypotensive effect of sympatholysis in the postoperative period 9 , but above all, the lack of convincing outcome benefits 10 . The MASTER trial prospectively evaluated 915 'high-risk' patients in an attempt to clarify previously demonstrated outcome benefits, but besides showing improved analgesia during the first three postoperative days and a reduction in respiratory complications, no significant benefit of epidural anaesthesia and analgesia was demonstrated.
The findings of this trial have been well publicised. Work done in Queensland found that 88% of specialists had read the paper 11 . Christchurch Hospital has an acute pain management service, which supervises use of epidural and intravenous analgesia in the postoperative period. Audit data from this service were reviewed to obtain the number of patients receiving epidural analgesia or intravenous patient-controlled analgesia (IV PCA) in the three years before and after the MASTER trial publication. To provide a more clearly defined study group we reviewed colonic surgery over the same period, comparing numbers for general anaesthesia plus epidural anaesthesia/analgesia against general anaesthesia plus IV PCA.
A questionnaire was sent to all the anaesthetists who had worked in Christchurch over that six-year period to help establish reasons for any change in practice.
MATERIALS AND METHODS
Christchurch Hospital is the largest hospital on the South Island of New Zealand with a broad mix of surgical specialities. Elective orthopaedic and all obstetric services are performed at separate sites and are not included in this audit.
In deciding on data to be collected, it was necessary to decide on a suitable denominator group to compare epidural usage against. We decided to use the total number of major analgesic interventions in the first instance. A major analgesic intervention was defined as the use of epidural analgesia or IV PCA.
The availability of the Acute Pain Management Service (APMS) data allowed retrospective audit of the 12-monthly totals of patients receiving postoperative epidural analgesia and IV PCA from June 1 to May 31 between 1999 and 2005.
The MASTER trial was published in The Lancet in April 2002, thus providing numbers for three years before and three years after the publication date. The pre-MASTER period deliberately includes the two months after the publication date as we considered that the defining event in dissemination of the MASTER study data to our local anaesthesia population was the presentation of findings at the May 2002 Australian and New Zealand College of Anaesthetists Annual Scientific Meeting.
We also reviewed the total number of colonic surgical cases performed, with and without epidural catheters placed in addition to general anaesthesia, between the years July 1999 and July 2005. All theatre data is coded according to the International Statistical Classification of Diseases and Related Health Problems. Colonic surgery is listed under Block 193 and includes right, left, subtotal and total colectomy. These data were obtained from the Clinical Coding department of Canterbury District Health Board, which is independent of the APMS.
The third part of the study was to send a questionnaire to all senior anaesthetists who had worked at Christchurch Hospital during that six-year period. The anaesthetists were unaware of the study findings when answering the first section of the questionnaire.
Data analyses were performed using the Chi square test (Web Chi Square Calculator) to analyse the number of epidural techniques versus IV PCA numbers for the APMS data and the number of general anaesthesia plus epidural anaesthesia or analgesia versus the number of general anaesthesia plus IV PCA for the colonic surgery patients, comparing usage before and after the MASTER trial publication.
RESULTS

APMS data
The mean number of epidural techniques performed during each 12-month epoch in the 36-month period prior to MASTER publication was 343. The 12-monthly mean in the three years after MASTER publication in 2002 was 197 (Table 1) . This represents a reduction of 43% and inspection of the data graphically ( Figure 1 ) shows a stepwise reduction around the time of MASTER publication.
Analysing the total number of epidural and IV PCA usages before and after release of the MASTER trial results revealed a significant reduction in epidural usage compared with IV PCA usage, before and after June 2002 (P<0.001).
Colonic surgery data
The epidurals performed specifically for colonic surgery show a similar proportionate reduction ( Figure 2 ). There was a 59% reduction in the frequency of epidural use for colonic surgery after the MASTER publication date (P<0.001). The proportion of cases in which an epidural was used in addition to general anaesthesia fell from 30 to 13%. 
Questionnaire
The questionnaire was sent to 37 specialist anaesthetists of whom 36 (97%) replied.
Twenty-seven (75%) considered they were performing fewer epidural techniques when comparing the past two years with a similar period four or five years ago. Not one anaesthetist considered he/she was performing more epidural techniques.
Twenty-five (69%) indicated that the findings of the MASTER trial had influenced their rate of epidural usage, resulting in a decline in epidural rates. When the anaesthetists were informed about the decrease in epidural rate locally in Christchurch Hospital, 31 (86%) said they were not surprised.
The final two questions asked for comments about the MASTER trial and as to whether the respondent had other reasons to explain the reduction in epidural rates. Common themes to explain this (besides the MASTER trial results) included surgical preference, concern about rare but devastating complications, inability to run low-dose vasopressor infusions for postoperative hypotension on the ward, recent use of wound catheters, the advent of spinal morphine techniques and the use of multimodal analgesic regimens. No single one of these other reasons stood out as a common theme.
DISCUSSION
The data presented show a reduction in usage of epidural anaesthesia and analgesia at Christchurch Hospital over the audit period. This reduction appears to have occurred chiefly in a stepwise fashion, around the time of the MASTER trial publication.
The question arises as to whether other influences could have precipitated this change in practice. As the data obtained from the APMS was not analysed by surgical type, it is possible that a change of patient mix presenting in our hospital could have accounted for the reduction. Also a change in analgesic strategy, such as the use of paravertebral catheters in thoracic surgery 12 , might have produced such a sudden change. While neither the experience of our APMS nurses nor the responses in our survey supported the latter postulate, we chose to review epidural usage in a more closely defined patient group where epidural usage was relatively common. Colonic surgery is one of the main indications for epidural analgesia and our results show that usage also declined significantly in this subgroup.
The combination of IV PCA with epidural analgesia to define the "major analgesic intervention group" could produce the impression of a proportionate decrease in epidural use if IV PCA use had increased. While PCA use did increase between the study periods, the increase was small compared to the reduction in epidural usage. Indeed some increase in IV PCA would be inevitable, because it represents the commonest alternative method to epidural analgesia. Therefore we believe the reduction in epidural analgesia use to be a genuine event, rather than an artefact produced by an increase in IV PCA usage.
It is well documented that the MASTER trial has been subject to significant criticism. This criticism has been chiefly aimed at poor protocol compliance, the lack of specific information about the epidural regimen and the fact that those patients in the epidural group were not also assigned to specific rapid rehabilitation programs.
However, the temporal association of MASTER publication with the decline in usage of epidural analgesia, together with the response of the surveyed specialists, suggests that MASTER trial publication was indeed associated with a major shift in practice in our institution. Three-quarters of the anaesthetists questioned felt they were performing fewer epidurals and 69% were of the opinion the MASTER trial had influenced their practice. While other factors undoubtedly existed, they had not gathered sufficient weight to precipitate the change. We believe MASTER trial findings acted as a 'tipping point' for a change in practice. This represents an interesting example of a single, prospective randomised study leading to reduction in use of a commonplace therapeutic option. This is borne out by the comments by the specialists surveyed, with examples being "The hypothesis that epidurals have a major advantage was not borne out, so their use is difficult to defend when many of the surgeons seem to dislike them"; "I became epidural phobic since the study" and "One study completely changed my practice". An interesting question that arises is whether the change in practice we observed is supported by the currently available evidence base. The Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine publication Acute Pain Management: Scientific Evidence, emphasises improved analgesia, bowel recovery and reduction in pulmonary complications associated with epidural anaesthesia and analgesia, although it recognises the difficulties in comparing studies of different drugs, at different levels, for different operations 13 . Ballantyne et al give a very balanced view of the positive and negative effects of epidural anaesthesia and analgesia, and thoroughly review the available evidence and stress that beneficial effects are more likely when epidural anaesthesia and analgesia is tailored to specific groups of patients 14 . Liu et al note that, given the increasing safety of surgical procedures, with low mortality and major morbidity, the numbers of patients required to demonstrate significant outcome differences in randomised controlled trials may be unfeasibly high. Instead they suggest looking at more patient-orientated outcomes such as quality of recovery, patient satisfaction and quality of life 15 . Such issues are at the core of much of the epidural anaesthesia and analgesia practice abroad. Along with some Australasian centres, many centres in the U.S. and Europe are pursuing "Fast-Track" or "Enhanced Recovery After Surgery" programs. These programs use epidural anaesthesia and analgesia in combination with minimally invasive surgical techniques, aggressive postoperative rehabilitation, early oral nutrition and ambulation. Such programs have not only been shown to shorten hospital stay but also lead to earlier resumption of normal activities, with less fatigue and need for sleep postoperatively 16, 17 . Not only does this appear to benefit patients (although readmission rates are possibly increased) but it is also logical in a healthcare system under increasing fiscal pressure. Indeed, a group from Auckland recently compared patients on an enhanced recovery program with matched historical controls and showed not only a shorter length of stay but also possible improvement in rates of immediate postoperative morbidity 18 . A shortcoming of this study was the failure to question anaesthetists about the fear of litigation, an issue highlighted by Power et al 11 . The climate for litigation is less marked in New Zealand compared with Australia, so it is less likely that fear of litigation is the driving force in reducing the frequency of epidural anaesthesia and analgesia. Another fault is the retrospective nature of the data collection and reliance on clinical coding for epidural numbers. However, any errors in coding are likely to have occurred across the two time periods and importantly should not affect the proportion of cases of epidural anaesthesia and analgesia combined with general anaesthesia.
In conclusion, this audit has shown a significant drop in epidural rates that occurred around the time of the MASTER trial's publication. In combination with similar work performed in Australia 11 , the results strongly suggest that selective interpretation of the available evidence-base for epidural anaesthesia and analgesia has resulted in a marked change in local practice in this field. However, given the changing role of epidural anaesthesia and analgesia, the focus on patient-centred outcomes and increasing fiscal pressures, it will be interesting to see if the rate of epidural anaesthesia and analgesia increases again. We plan to repeat our review of local data to see if this occurs or if other analgesic regimens, such as intrathecal morphine, become ascendant.
